Previous 10 | Next 10 |
2024-05-26 08:31:00 ET Viking Therapeutics (NASDAQ: VKTX) stock is soaring. Two years ago, the share price hovered just above $2. Today, shares trade around $62. At Friday's prices, a paltry $100 investment in 2022 would have grown to more than $2,700! Is there still time for yo...
2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...
2024-05-24 06:30:00 ET Things aren't so bad for investors right now. We are in a bull market even though the economy is still having some problems. However, this bull run won't last forever. There will be a slowdown, equities will fall, and many won't deliver anything approaching decent ret...
2024-05-20 07:02:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Russell 2000 is a stock market index comprised of 2,000 companies that have small market capitalizations. A small-cap stock is generally any security of a publicly traded company wh...
2024-05-18 11:18:53 ET Summary Roche's obesity candidate CT-388 showed positive results in a phase 1b trial, with an 18.8% placebo-adjusted weight loss at week 24. The full data presentation is needed to assess safety and tolerability and how CT-388 stacks up against key competito...
2024-05-18 06:47:00 ET If you go to California's Redwood National Park, you can see the world's tallest tree -- a redwood called Hyperion that's over 380 feet tall. Like every other tree, though, Hyperion started as a small seed. Stocks can be like this, beginning small but growing to a...
2024-05-17 14:15:51 ET Summary Roche's acquisition of Carmot Therapeutics and their obesity drug CT-388 showed promising Phase 1b results, boosting Roche's stock by 4%. CT-388 demonstrated significant weight loss but lacked detailed safety data, making comprehensive evaluation cha...
2024-05-16 15:15:03 ET Raymond James analyst issues STRONG BUY recommendation for VKTX on May 16, 2024 01:43PM ET. VKTX was trading at $69.81 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy recomm...
2024-05-16 15:00:04 ET Joon Lee from Truist Financial issued a price target of $120.00 for VKTX on 2024-05-16 13:44:00. The adjusted price target was set to $120.00. At the time of the announcement, VKTX was trading at $69.525. The overall price target consensus is at $7...
2024-05-16 13:37:18 ET More on Viking Therapeutics What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired Viking Therapeutics, Inc. (VKTX) Q1 2024 Earnings Call Transcrip...
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
2024-07-20 06:00:00 ET California's giant redwood trees were once tiny sprouts or seeds. Likewise, the world's biggest companies were once much smaller. Trees and companies can grow significantly over time -- at least some of them. Three Motley Fool contributors think they've found bi...
2024-07-19 05:50:00 ET Fortunes have been made on biotech stocks over the last few decades. The secret to success has been to invest in an up-and-coming biotech company before it even had a product on the market. Ideally, the company would have a pipeline featuring multiple promising candid...
Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024 PR Newswire Conference Call Scheduled for Wednesday, July 24 at 4:30 p.m. Eastern Time SAN DIEGO , July 17, 2024 /PRNewswire/ -- Viking Therapeutics, Inc...